A review of Candida species causing blood stream infection

Indian Journal of Medical Microbiology

Volumn 30, Issue 3, 2012, Pages 270-278

  Giri, S ^a   Kindo, A J ^b  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^b SRI RAMACHANDRA UNIVERSITY   (India)

Author keywords

Antifungals; candidemia; echinocandins; immunocompromised

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE; ITRACONAZOLE; MICAFUNGIN; TRIAZOLE; VORICONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE KIDNEY FAILURE; ANTIBIOTIC THERAPY; ANTIFUNGAL SUSCEPTIBILITY; BLOOD CULTURE; BRAIN HEMORRHAGE; CANCER CHEMOTHERAPY; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA RUGOSA; CANDIDA TROPICALIS; CANDIDEMIA; CANDIDURIA; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHILDHOOD DISEASE; DIABETES MELLITUS; DRUG TREATMENT FAILURE; FUNGAL COLONIZATION; GASTROINTESTINAL SURGERY; HEART ASSIST DEVICE; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INDIA; INTENSIVE CARE; INTRAVASCULAR CATHETER; KLUYVEROMYCES MARXIANUS; LENGTH OF STAY; LIVER TRANSPLANTATION; LOW BIRTH WEIGHT; MORBIDITY; NEPHROTOXICITY; NEUTROPENIA; NONHUMAN; PARENTERAL NUTRITION; PICHIA ANOMALA; PREOPERATIVE CARE; PROGNOSIS; REVIEW; SEPTICEMIA;

EID: 84865605029     PISSN: 02550857     EISSN: 19983646     Source Type: Journal    
DOI: 10.4103/0255-0857.99484     Document Type: Review

References (58)

1. Wisplinhoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004;39:309-17.
2. Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: A propensity analysis. Clin Infect Dis 2005;41:1232-9.
3. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: A persistent public health problem. Clin Microbiol Rev 2007;20:133-63.
4. Marchetti O, Bille J, Fluckiger U, Eggimann P, Ruef C, Garbino J. Epidemiology of candidemia in swiss tertiary care hospitals: Secular Trends, 1991-2000. Clin Infect Dis 2004;38:311-20.
5. Poikonen E, Lyytikainen O, Antilla VJ, Ruutu P. Candidemia in Finland, 1995-1999. Emerg Infect Dis 2003;9:985-90.
6. Sandven P, Bevanger L, Digranes A, Haukland HH, Mansaker T, Gaustad P. Candidemia in Norway (1991 to 2003): Results from a nationwide study. J Clin Microbiol 2006;44:1977-81.
7. Colombo AL, Nucci M, Park BJ, Nouer SA, Arthington-Skaggs B, daMatta DA. Epidemiology of candidemia in Brazil: A nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol 2006;44:2816-23.
8. Tritipwanit K, Chindamporn A, Suankratay C. Epidemiology of candidemia at King Chulalongkorn Memorial Hospital, Thailand. J Infect Dis Antimicrob Agents 2005;22:59-69.
9. Verma AK, Prasad KN, Singh M, Dixit AK, Ayyagari A. Candidaemia in patients of a tertiary health care hospital from north India. Indian J Med Res 2003;117:122-8.
10. Kothari A, Sagar V. Epidemiology of Candida Bloodstream Infections in a Tertiary Care Institute in India. Indian J Med Microbiol 2008;27:171-2.
11. Kumar CP, Sundararajan T, Menon T, Venkatadesikalu M. Candidiosis in children with onco-hematological studies in Chennai,South India. Jpn J Infect Dis 2005;58:218-21.
12. Goel N, Ranjan PK, Agarwal R, Chaudhary U, Sanjeev N. Emergence of nonalbicans Candida in neonatal septicemia and antifungal susceptibility: Experience from a tertiary care centre. J Lab Physicians 2009;1:53-5.
13. Xess I, Jain N, Hasan F, Mandal P, Banerjee U. Epidemiology of candidemia in a tertiary care centre of North India: 5-Year Study. Infection 2007;35:256-9.
14. Sahni V, Agarwal SK, Singh NP, Anuradha S, Sikdar S, Wadhwa A. Candidemia - An Under-recognized nosocomial infection in Indian Hospitals. J Assoc Physicians India 2005;53:607-11.
15. Walsh TJ, Rex JH. All catheter-related candidemia is not the same: Assessment of the balance between the risks and benefi ts of removal of vascular catheters. Clin Infect Dis 2002;34:600-2.
16. Nucci M, Marr KA. Emerging fungal diseases. Clin Infect Dis 2005;41:521-6.
17. Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: The NEMIS Prospective Multicenter Study. Clin Infect Dis 2001;33:177-86.
18. Al-Attas SA, Amro SO. Candidal colonisation, strain diversity and antifungal susceptibility among adult diabetic patients. Ann Saudi Med 2010;30:101-8.
19. Shoham S, Shaffer R, Sweet L, Cooke R, Donegan N, Boyce S. Candidemia in patients with ventricular assist devices. Clin Infect Dis 2007;44:e9-12.
20. Gordon SM, Schmitt SK, Jacobs M, Smedira NM, Goormastic M, Banbury MK. Nosocomial bloodstream infections in patients with implantable left ventricular assist devices. Ann Thorac Surg 2001;72:725-30.
21. Wenzel RP. Nosocomial candidemia: Risk factors and attributable mortality. Clin Infect Dis 1995;20:1531-4.
22. Wenzel RP, Gennings C. Bloodstream infections due to Candida species in the intensive care unit: Identifying especially high-riskpatients to determine prevention strategies. Clin Infect Dis 2005;41:S389-93.
23. Shorr AF, Tabak YP, Johannes RS, Sun X, Splading J, Kollef MH. Candidemia on presentation to the hospital: Development and validation of a risk score. Crit Care 2009;13:1-10.
24. Blythe CC, Chen SC, Slavin MA, Serena C, Nguyen Q, Marriott D. Not just little adults: Candidemia Epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients. Pediatrics 2009;123:1360-8.
25. Lee BE, Cheung PY, Robinson JL, Evanochko C, Robertson CM. Comparative study of mortality and morbidity in premature infants (Birth Weight, 1,250 g) with Candidemia or Candidal Meningitis. Clin Infect Dis 1998;27:559-65.
26. Gupta N, Mittal N, Sood P, Kumar S, Kaur R, Mathur MD. Candidemia in neonatal intensive care Unit. Indian J Pathol Microbiol 2001;44:45-8.
27. Heitner SB, Eiger G, Fischer R, Scott EC, Somers A. Risk factors for candidemia: Comparison between medical and surgical intensive care unit patients. Chest 2005;128:379S-80.
28. Nieto-Rodriguez JA, Kusne S, Manez R, Irish W, Linden P, Magnone M. Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients. Ann Surg 1996;223:70-6.
29. Yamamura DL, Rotstein C, Nicolle LE, Loannou S. The fungal disease registry of the canadian infectious disease society. Candidemia at selected canadian sites: Results from the Fungal Disease Registry, 1992-1994. Can Med Assoc J 1999;160:493-9.
30. Pfaller MA, Diekema DJ, Rinaldi MG, Barnes R, Hu B, Veselov AV. Results from the ARTEMIS DISK Global antifungal surveillance study: A 6.5-year analysis of susceptibilities of Candida and other yeast species to fl uconazole and voriconazole by standardized disk diffusion testing. J Clin Microbiol 2005;43:5848-59.
31. Trick WE, Fridkin SK, Edwards JR, Hajjeh RA, Gaynes RP. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989- 1999. Clin Infect Dis 2002;35:627-30.
32. Malani A, Hmoud J, Chiu L, Carver PL, Bielaczyc A, Kauffman CA. Candida glabrata fungemia: Experience in a tertiary care center. Clin Infect Dis 2005;41:975-81.
33. Kothavade RJ, Kura MM, Valand AG, Panthaki MH. Candida tropicalis: Its prevalence, pathogenicity and increasing resistance to fl uconazole. J Med Microbiol 2010;59:873-80.
34. Shivaprakasha S, Radhakrishnan K, Karim PM. Candida spp other than Candida albicans: A Major Cause of Fungemia in a Tertiary Care Centre. Indian J Med Microbiol 2007;25:405-7.
35. Adhikary R, Joshi S. Species distribution and antifungal susceptibility of candidemia at a multi super specialty centre in Southern India. Indian J Med Microbiol 2011;29:309-11.
36. Levy I, Rubin LG, Vasistha S, Tucci V, Sood SK. Emergence of Candida parapsilosis as the predominant species causing candidemia in children. Clin Infect Dis 1998;26:1086-8.
37. Baradkar VP, Mathur M, Kumar S. Neonatal Septicemia in a premature infant due to Candida dublinensis. Indian J Med Microbiol 2008;26:382-5.
38. Agarwal S, Thakur K, Kanga A, Singh G, Gupta P. Catheter related candidemia caused by Candida lipolytica in a child with tubercular meningitis. Indian J Pathol Microbiol 2008;51:298-300.
39. Horn DL, Neofytos D, Anaissie E, Fishman JA, Steinbach WJ, Olyaei AJ. Epidemiology and outcomes of candidemia in 2019 Patients: Data from the prospective antifungal therapy alliance registry. Clin Infect Dis 2009;48:1695-703.
40. White TC. Mechanisms of Resistance to Antifungal Agents. In: Murray PK, Baron EJ, Landry ML, Jorgensen JJ, Pfaller MA, editors. Manual of clinical microbiology. 9th ed. Washinton D.C.: ASM Press; 2007. p. 1961-71.
41. Pfaller MA, Diekema DJ. Twelve years of fl uconazole in clinical practice: Global trends in species distribution and fl uconazole susceptibility of bloodstream isolates of Candida. Clin Microbiol Infect 2004;10 Suppl 1:S11-23.
42. Nolte FS, Parkinson T, Falconer DJ, Dix S, Williams J, Gilmore C. Isolation and characterisation of fl uconazole and amphotericin B resistant Candida albicans from blood of two patients with leukaemia. Antimicrob agents chemother 1997;41:196-9.
43. Pfaller MA, Boyken L, Hollis RJ, Messer SA, Tendolkar S, Diekema DJ. In vitro susceptibilities of Candida species to caspofungin: Four years of global surveillance. J Clin Microbiol 2006;44:760-3.
44. Krogh-Madsen M, Arendrup MC, Heslet L, Knudsen JD. Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient. Clin Infect Dis 2006;42:938-44.
45. Lee KK, MacCallum DM, Jacobsen MD, Walker LA, Odds FC, Gow NA, et al. Elevated cell wall chitin Candida albicans confers echinocandin resistance in vivo. Antimicrob agents chemother 2012;56:208-17.
46. Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwards JE. Clinical practice guidelines for the management of candidiasis: 2009 Update by the infectious diseases society of america. Clin Infect Dis 2009;48:503-35.
47. Ito JI, Hooshmand-Rad R. Treatment of Candida infections with amphotericin B lipid complex. Clin infect dis 2005;40:S384-91.
48. Wong-Beringer A, Jacobs RA, Guglielmo BJ. Lipid Formulations of Amphotericin B: Clinical effi cacy and toxicities. Clin Infect Dis 1998;27:603-18.
49. Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ. Guidelines for treatment of candidiasis. Clin Infect Dis 2004;38:161-89.
50. Rex JH, Pappas PG, Karchmer AW, Sobel J, Edwards JE, Hadley S. A randomized and blinded multicenter trial of high-dose fl uconazole plus placebo versus fl uconazole plus amphotericin B as therapy of candidemia and its consequences in nonneutropenicsubjects. Clin Infect Dis 2003;36:1221-8.
51. Nucci M, Perfect Jr. When Primary Antifungal Therapy Fails. Clin Infect Dis 2008;46:1426-33.
52. Mermel LA, Farr BM, Sherertz RJ, Raad II, O'Grady N, Harris JS. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001;32:1249-72.
53. Nucci M, Anaissie E. Should Vascular Catheters Be Removed from all patients with candidemia? An evidence-based review. Clin Infect Dis 2002;34:591-9.
54. Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: A potential risk factor for hospital mortality. Antimicrob agents chemother 2005;49:3640-5.
55. Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Donowitz LJ. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 2001;23:1660-6.
56. Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ. Posaconazole vs fl uconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 2007;356:348-59.
57. Chowta MN, Adhikari P, Rajeev A, Shenoy AK. Study of risk factors and prevalence of invasive candidiasis in a Tertiary care hospital. Indian J Crit Care Med 2007;11:67-73.
58. Capoor MR, Nair D, Deb M, Verma PK, Srivastava L, Aggarwal P. Emergence of non-albicans Candida species and antifungal resistance in a tertiary care hospital. Jpn J Infect Dis 2005;58:344-8.